Loading...

Table of Content

    31 July 2017, Volume 32 Issue 7
    Orginal Article
    Standardization for the determination of lipoprotein(a)
    FENG Renfeng
    2017, 32(7):  555-560.  DOI: 10.3969/j.issn.1673-8640.2017.07.001
    Asbtract ( 341 )   HTML ( 6)   PDF (2904KB) ( 665 )  
    Figures and Tables | References | Related Articles | Metrics

    Lipoprotein(a)[Lp(a)] is a predictive factor for evaluating the risk of cardiovascular diseases. However,there is no comparability for the results of Lp(a) determinations. So,Lp(a) determination can not be applied widely. Although its reference method and reference materials have been established in 2003,until now,commercial reagents expressing the results as nmol/L just appear. Then,determination results can be traced to World Health Organization (WHO)/ the International Federation of Clinical Chemistry and Laboratory Medicine(IFCC)standard reference material(SRM)2B. This article introduces the causes of result inconsistency,the progress of Lp(a) determination standardization and a valuable example about Roche research. In the guidance of Professor Marcovina from the Northwest Lipid Research Laboratories(NWLRL)at the University of Washington,Roche overcomes the influence of apolipoprotein (apo)(a) kringle structure on the determination of Lp(a),which makes routine determination system being traceable to WHO/IFCC SRM 2B and related results with comparability.

    Lipoprotein (a):a vital member of blood lipid items
    QIAO Rui, ZHANG Jie
    2017, 32(7):  561-565.  DOI: 10.3969/j.issn.1673-8640.2017.07.002
    Asbtract ( 362 )   HTML ( 5)   PDF (1233KB) ( 738 )  
    Figures and Tables | References | Related Articles | Metrics

    Lipoprotein (a) [Lp(a)] consists of a low-density lipoprotein (LDL)-like particle and apolipoprotein (apo)(a) . The level of plasma Lp(a) is mainly determined by its genetic factors,including highly polymorphic copy number variation of kringleⅣ repeats and single nucleotide polymorphism at LPA gene locus. Due to its size variation,the standardization of Lp(a) determination is uncertain. It has been confirmed that there is an association between elevated Lp(a) and cardiovascular disease (CVD) in numerous studies. Lp(a) may have pro-inflammatory, pro-atherogenic and pro-thrombogenic properties and thus causes or promotes CVD. This review mainly focuses on Lp(a) structure,metabolism,genetics,determination and its relationship with CVD.

    Consistency of different systems for determining lipoprotein(a)
    TANG Wenjia, WU Jiong, WANG Beili, GUO Wei, PAN Baishen
    2017, 32(7):  566-569.  DOI: 10.3969/j.issn.1673-8640.2017.07.003
    Asbtract ( 302 )   HTML ( 6)   PDF (1222KB) ( 645 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To evaluate the consistency of different systems for determining lipoprotein(a) [Lp(a)],and to investigate whether calibrators can improve the consistency or not. Methods A total of 6 different kinds of Lp(a) reagents(Roche,BSBE,Diasys,Yunda,Medicalsystem and Maccura)were chosen,and they were combined with Hitachi 7600 automatic analyzer separately to set up different systems. A total of 51 samples were collected,and each sample was determined by 6 different systems. Roche system was as a reference system,and the samples were retested by the other 5 systems after being calibrated by Roche system. The results of same sample that was determined by different systems before and after calibration were compared. Results There was difference for the determination of Lp(a) among different systems [the mean of coefficient of variation (CV) was 29.8%,and the median of CV was 28.9%]. However,the difference could be decreased after calibration (the mean of CV was 17.6%,and the median of CV was 13.3%]. The intercept of regression equation of each system to the reference system reduced after calibration. The results still can not be exchanged by conversion factor. The difference between the results from Roche system and the other systems was decreased after calibration. Compared with the reference system,the proportions of bias < ±30% and < ±15% were increased. Conclusions The results from different systems have difference. When calibrating systems by using the same calibrator,the difference of results can be decreased,but it still can not be completely eliminated.

    Comparison between a lipoprotein (a) particle concentration assay and 2 kinds of lipoprotein (a) mass concentration assays
    JIA Keke, QIN Yanfei, YANG Shuo, ZHANG Jie
    2017, 32(7):  570-576.  DOI: 10.3969/j.issn.1673-8640.2017.07.004
    Asbtract ( 340 )   HTML ( 10)   PDF (1249KB) ( 677 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To evaluate the performance of a new lipoprotein (a) [Lp (a)] particle concentration assay (method A) and 2 kinds of Lp(a) mass concentration assays(method B and method C). Methods The precisions,linear ranges and clinical reportable ranges of the 3 methods were evaluated. The Lp(a) levels of 322 samples were determined by the 3 methods. Applying 75 nmol/L as the cut-off value for method A,and 300 mg/ L for method B and method C,the positive rates of the 3 methods in coronary artery disease (CAD),peripheral artery disease (PAD),cerebral stroke and healthy control groups were compared. Results The precisions,linear ranges and recovery rates of the 3 methods were acceptable. The clinical reportable ranges of the 3 methods were 0.8-920.0 nmol/ L,1-4 000 mg/L and 3-1 960 mg/L. Method B showed a good correlation with method A(R2=0.932),while method C showed a poor correlation with method A(R2=0.631). Compared to method A,Lp(a) levels were overestimated in 11.8% samples for method B and 13.7% samples for method C,and were underestimated in 3.1% samples for method C. Compared to healthy control group,Lp(a) levels of CAD,PAD and cerebral stroke groups all showed statistical significance(P<0.001). The positive rate of method A in healthy control group was low,and there was no statistical significance for the positive rates of the 3 methods (P>0.05). The positive rates of method B and method C in CAD and PAD groups were higher than those of method A (P<0.05). The positive rate of method B in cerebral stroke group had no statistical significance with that of method A(P>0.05),and that of method C was higher than that of method A (P<0.001). Conclusions Method A for Lp (a) particle concentration can be traced to standard reference material(SRM)2B,and can reflect Lp(a) level correctly. Method B and method C for Lp(a) mass concentration overestimate Lp(a) levels compared with particle concentration. The levels of Lp(a) for predicting the risks of cardio vascular disease,PAD and cerebral stroke can be affected by the selection of methods and cut-off values.

    Inhibitory activity of Chinese medicine coptischinensisfranch against Staphylococcus aureus in vitro
    YAO Dongting, HU Jun, ZHANG Xueqing, HU Xiaobo
    2017, 32(7):  577-581.  DOI: 10.3969/j.issn.1673-8640.2017.07.005
    Asbtract ( 277 )   HTML ( 5)   PDF (896KB) ( 628 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To observe the inhibitory activity of Chinese medicine coptischinensisfranch against Staphylococcus aureus in vitro. Methods A total of 71 Staphylococcus aureus isolates were collected from Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine from January to April 2016. Broth micro-dilution method was used with Staphylococcus aureus ATCC 25913 as quality control isolate to observe the inhibitory activity of coptischinensisfranch. Results A total of 71 Staphylococcus aureus isolates were collected,and there were 21 isolates of methicillin-resistant Staphylococcus aureus (MRSA). The minimal inhibitory concentration (MIC) of coptischinensisfranch against 71 isolates of Staphylococcus aureus was from 3.91 mg/mL to 31.25 mg/mL,and there was no statistical significance between MRSA and methicillin-sensitive Staphylococcus aureus (MSSA)(P>0.05). Among the 71 isolates,52 isolates (73.24%) were isolated from pus/secretion specimens,while 19 isolates (26.76%)were isolated from the other specimens,and there was no statistical significance for the inhibitory activity of coptischinensisfranch against Staphylococcus aureus in vitro among different specimens(P>0.05). Among the 71 isolates,40 isolates (56.34%)were isolated from surgical inpatients,25 isolates(35.21%)were isolated from the other ward inpatients,6 isolates (8.45%)were isolated from outpatients,and there was no statistical significance for the inhibitory activity of coptischinensisfranch against Staphylococcus aureus in vitro among different wards (P>0.05). Conclusions Coptischinensisfranch has a good inhibitory activity against the clinical isolates of Staphylococcus aureus,and it can be used for the treatment of Staphylococcus aureus infection,especially for MRSA infection.

    Standard for judging the morphology of urinary red blood cells
    LIU Jinxiang, DING Yong, CAO Cuiyun, PAN Yan
    2017, 32(7):  582-585.  DOI: 10.3969/j.issn.1673-8640.2017.07.006
    Asbtract ( 259 )   HTML ( 3)   PDF (1110KB) ( 458 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To seek a functional standard for the diagnosis of glomerular hematuria with little subjectivity. Methods Firstly,feature-deformed red blood cells(ring-,target- and spore- shaped red blood cells) were determined by light microscope,and its percentage in 150 diagnosed patients after renal biopsy was analyzed. Cut-off values were classified. The sensitivity and specificity were calculated,and receiver operating characteristic (ROC) curve was drawn. The area under ROC curve(AUC) was calculated. Results There were >30% feature-deformed red blood cells in patients with glomerular hematuria,while there were <10% feature-deformed red blood cells in patients without glomerular hematuria. Taking feature-deformed red blood cells >30% as standard for the diagnosis of glomerular hematuria,the sensitivity was 84%,the specificity was 97%,and the AUC was 0.976. Meanwhile,the opportunity of processing mixed hematuria decreased. Conclusions Ring-,target- and spore-shaped red blood cells are practical for the diagnosis of glomerular hematuria.

    MicroRNA-1246 in patients with breast cancer
    WANG Pan, ZHU Jie, GU Wanhong, LI Zhaoyun
    2017, 32(7):  586-589.  DOI: 10.3969/j.issn.1673-8640.2017.07.007
    Asbtract ( 180 )   HTML ( 1)   PDF (973KB) ( 492 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To analyze the expression of microRNA(miRNA)-1246 in sera and tissues among breast cancer patients,and to investigate the role of serum miRNA-1246 in the diagnosis of breast cancer. Methods Fluorescence quantitation polymerase chain reaction (PCR) was used to determine the expression of miRNA-1246 in sera of 100 breast cancer patients and 40 healthy controls,in 30 cases of breast cancer tissues and 15 cases of breast cancer adjacent tissues. Results The expression of miRNA-1246 was higher in sera of breast cancer patients than that in sera of healthy controls (P<0.05). There was no statistical significance for miRNA-1246 expression between breast cancer tissues and breast cancer adjacent tissues (P>0.05). Serum miRNA-1246 had an area under receiver operating characteristic(ROC) curve of 0.904,with sensitivity of 93% and specificity of 75%. Conclusions Serum miRNA-1246 shows good sensitivity and specificity for diagnosing breast cancer,and can be used as a potential tumor marker.

    Analysis of 21-gene recurrence score in 459 patients with breast cancer
    LIN Jiafei, WU Jiayi, CAI Gang, WU Beiying, LIN Lin
    2017, 32(7):  590-596.  DOI: 10.3969/j.issn.1673-8640.2017.07.008
    Asbtract ( 255 )   HTML ( 2)   PDF (1087KB) ( 1131 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To investigate the distribution characteristics of 21-gene recurrence score and its correlation with clinicopathologic characteristic in breast cancer patients,and to evaluate the role in the choice of adjuvant chemotherapy. Methods A total of 459 patients with breast cancer were enrolled,who are with positive estrogen receptor(ER) and negative human epidermal growth factor receptor 2(HER2). RNA was extracted from the paraffin specimens of patients. Real-time fluorescence polymerase chain reaction (PCR) was used to determine the expression of 21-gene,and recurrence score was calculated. According to recurrence score,the patients were classified into low,intermediate and high risk groups. The relationship with clinicopathologic characteristic and the choice of adjuvant chemotherapy in recurrence score groups were evaluated. Multivariate Logistic regression analysis was used to analyze the influence factors for recurrence score. Results Among the 459 patients with breast cancer,there were 117 patients (25.5%) in low risk group,254 patients (55.3%) in intermediate risk group and 88 patients (19.2%) in high risk group. There was statistical significance in tumor grade,type,progestin receptor(PR) status and Ki67 expression among recurrence score groups(P<0.05). Multivariate Logistic regression analysis showed that PR status and tumor grade were influence factors for recurrence score. There were differences in the proportions of receiving adjuvant chemotherapy among recurrence score groups(P<0.05). Conclusions Recurrence score can effectively integrate some important conventional clinical and pathological indicators,and provide more information. Recurrence score can also support the choice of adjuvant chemotherapy.

    Relationship of cystatin C and single nucleotide polymorphisms with coronary heart disease in Guangxi
    HUANG Shengxian, ZHENG Liping, YANG Lan, LU Junjia, ZHU Xu
    2017, 32(7):  597-602.  DOI: 10.3969/j.issn.1673-8640.2017.07.009
    Asbtract ( 148 )   HTML ( 1)   PDF (1802KB) ( 432 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To investigate the relationship of cystatin C (Cys C) and +73A/G and -82G/C single nucleotide polymorphisms with coronary heart disease (CHD) in Guangxi. Methods Serum levels of Cys C in Zhuang CHD patients,Zhuang healthy subjects,Han CHD patients and Han healthy subjects(100 cases for each group) were determined by immunoturbidimetric assay,and +73A/G and -82G/C single nucleotide polymorphisms were determined by polymerase chain reaction(PCR)-restriction fragment length polymorphism (RFLP). The clinical information was collected. Results Serum Cys C levels and clinical information between CHD patients and healthy subjects had statistical significance (P<0.05). The frequency of Cys C +73A/G polymorphism in CHD patients had statistical significance with that in healthy subjects(P<0.05). Serum Cys C levels in CHD patients with GG genotype were lower than those with AG and AA genotypes(P<0.05). There was no statistical significance between AG and AA genotypes (P>0.05) . Serum levels of Cys C had positive correlations with creatinine (Cr) levels and Cys C +73A/G polymorphism in CHD patients(r =0.60,P<0.01;r =0.42,P<0.01). Conclusions The increasing of serum Cys C levels caused by the decreasing of renal function covers the low levels of Cys C caused by Cys C +73A/G polymorphism. The polymorphism of Cys C +73A/G Polymorphism resulting low-level Cys C may be a risk factor for CHD in Guangxi.

    Changes of granulocyte-macrophage colony-stimulating factor and myeloperoxidase levels in bronchoalveolar lavage fluid among asthmatic children
    XU Qinglei, ZHOU Hong, MA Xiaobo, ZHANG Wei, LIU Lingling, LIU Gang, ZHANG Min
    2017, 32(7):  603-606.  DOI: 10.3969/j.issn.1673-8640.2017.07.010
    Asbtract ( 183 )   HTML ( 0)   PDF (947KB) ( 444 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To investigate the roles of granulocyte-macrophage colony-stimulating factor (GM-CSF)and myeloperoxidase (MPO) in bronchoalveolar lavage fluid(BALF)among asthmatic children. Methods A total of 29 asthmatic children and 25 controls were enrolled. By microscopy,the percentage of neutrophil(NEU)was determined. The levels of GM-CSF and MPO were determined by enzyme-linked immunosorbent assay. Results The levels of GM-CSF in BALF were (164.8±34.0) ng/L in attack stage group,(129.5±30.4) ng/L in remission stage group and(123.0±25.7)ng/L in control group. The levels of MPO were (25.1±9.7),(15.5±4.4)and(13.8±3.5)ng/L in the 3 groups,respectively. The percentages of NEU were (35.1±7.6)%,(26.3±6.2)% and(23.8±5.5)% in the 3 groups,respectively. The levels of GM-CSF and MPO in BALF and the percentages of NEU were higher in attack stage group than those in remission stage and control groups(P<0.01),but there was no statistical significance between remission stage and control groups (P>0.05). GM-CSF level was correlated positively with MPO level and the percentage of NEU(r = 0.665 and 0.504,P<0.01),and the percentage of NEU was correlated positively with MPO level(r = 0.669,P<0.01)in attack stage group. Conclusions Both GM-CSF and MPO levels increase among asthmatic children,and they might be involved in the pathological process of asthma. GM-CSF and MPO in BALF may be indices for evaluating and monitoring the status of children with asthma.

    Efficiency evaluation of carbapenem inactivation method for screening carbapenemase-producing Enterobacteriaceae
    YU Jiajia, LIU Ying, YU Jing, LI Yuanrui, LIU Jingxian
    2017, 32(7):  628-632.  DOI: 10.3969/j.issn.1673-8640.2017.07.017
    Asbtract ( 200 )   HTML ( 0)   PDF (1508KB) ( 458 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To evaluate the efficiency of carbapenem inactivation method (CIM)for screening carbapenemase-producing Enterobacteriaceae. Methods The results of polymerase chain reaction(PCR)and DNA sequencing for determining carbapenemase genes were used as gold standard. A total of 154 clinical isolates of Enterobacteriaceae were determined by CIM,and the results were compared with those of modified Hodge test. Results The consistency rate,specificity and sensitivity of CIM were 99.4%,96.6% and 100.0%,respectively. The consistency rate,specificity and sensitivity of modified Hodge test were 98.7%,93.1% and 100.0%,respectively. Conclusions In comparison to modified Hodge test,CIM shows high consistency rate and specificity. The observation of CIM results is easier than that of modified Hodge test. Therefore,CIM is suitable for using in all level microbiological laboratories.

    Performance evaluation of automatic genetic screening processor for neonatal screening
    TIAN Guoli, WANG Yanmin, ZHOU Zhuo, GUO Jing, XU Hongping, YAO Jing
    2017, 32(7):  633-636.  DOI: 10.3969/j.issn.1673-8640.2017.07.018
    Asbtract ( 290 )   HTML ( 1)   PDF (856KB) ( 708 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To evaluate the performance of automatic genetic screening processor(GSP)for neonatal screening. Methods According to the Clinical and Laboratory Standards Institute (CLSI)EP15-A2 document,thyroid stimulating hormone(TSH),17-OH-progesterone(17-OHP),phenylalanine(Phe) and glucose-6-phosphate dehydrogenase(G6PD) were determined in neonatal screening for congenital hypothyroidism(CH),congenital adrenal hyperplasia(CAH),phenylketonuria(PKU) and G6PD deficiency. The precisions,accuracies and linear ranges of 4 indices were verified. The results were compared with common methods (fluorescence enzyme immunoassay for TSH and 17-OHP and fluorescence assay for Phe and G6PD). Results The within-run imprecision and total imprecision were acceptable,and were similar to those published by manufacturers. The biases were <1/2 allowable total error (TEa) from -8.37% to 12.96%,comparing with the neonatal screening quality assurance program of the U. S. Centers for Disease Control and Prevention(CDC). The b of linear regression equation was 0.83-1.69,and r2 was >0.95,which was above the manufacturers declared(r2≥0.90). The results between GSP and the common methods had good consistency (Kappavalues were 0.83,0.73,0.93 and 0.97,P<0.001)and high correlation(r =0.97,0.94,0.99 and 0.91,P<0.001). Conclusions The precision,accuracy and linear range of GSP have been achieved the performance of manufacturers' declaration and could be used for neonatal screening.

    Electrochemical immunosensor for the determination of human epididymis-specific protein 4:a new method
    LU Lingsong, LIU Bei, LENG Jianhang, MA Xiao
    2017, 32(7):  637-641.  DOI: 10.3969/j.issn.1673-8640.2017.07.019
    Asbtract ( 154 )   HTML ( 0)   PDF (1245KB) ( 349 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To establish an electrochemical immunosensor for the determination of human epididymis-specific protein 4 (HE4) based on Graphene sheet and Au nanoparticle nanocomposite. Methods Firstly,Graphene sheet and Au nanoparticle nanocomposite was coated onto screen printed electrode(SPE) with an enhanced electrochemical active area and good electronic transfer property. HE4 antibody was adsorbed on the nanocomposite,which aimed at assembling more HE4 antigen. Following the immunoreaction with HE4,a double-antibody sandwich immunoassay was performed on SPE using horseradish peroxidase labeled HE4 antibody. Electrochemical detection was carried out for HE4 level in the presence of hydrogen dioxide(H2O2). Results The immunosensor showed broad linear response to the HE4 level comprised between 0 pmol/L and 400 pmol/L with a limit of detection(LOD)of 0.5 pmol/L. Conclusions The electrochemical immunosensor allows the identification of patients at risk of ovarian cancer,providing a new,fast and simple approach for early diagnosis in daily clinical practice.

    Measurement uncertainties for the determinations of serum K+,Na+ and Cl- and their quality improvement
    PAN Xilong, LIU Xiaodong, HUANG Shaofen
    2017, 32(7):  642-646.  DOI: 10.3969/j.issn.1673-8640.2017.07.020
    Asbtract ( 177 )   HTML ( 3)   PDF (853KB) ( 564 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To evaluate the measurement uncertainties(MU)for the determinations of serum potassium ion(K+),sodium ion(Na+)and chlorinum ion(Cl-)by ion selective electrode(ISE),and to improve the quality. Methods According to the Medical Laboratory-Evaluation and Expression of Uncertainty of Measurement published by China National Accreditation Service for Conformity Assessment(CNAS)in 2012,the relative expanded uncertainties(Urel)of serum K+,Na+ and Cl- were assessed by "top-down" method with the data of internal quality control(IQC)and external quality assessment(EQA). The 2 main components [bias Ucrel(bias)and reproducibility Urel(Rw)] were set as goals. When the Ucrel(bias)or Urel(Rw)was beyond the goals,the accuracy or precision should be improved further. Results When the levels of K+ were 3.64-4.41 and 5.70-7.00 mmol/ L,the MU were 8.84% and 7.76%,respectively,the Ucrel(bias)were beyond the goals,the Urel(Rw)were not beyond the goals,and the accuracy should be improved. When the levels of Na+ were 106-122 and 130-152 mmol/L,the MU were 5.20% and 4.60%,the Ucrel(bias)and Urel(Rw)were beyond the goals,and the accuracy and precision should be improved. When the levels of Cl- were 68.9-78.3 and 96.4-107.9 mmol/L,the MU were 7.15% and 6.86%,the Ucrel(bias)and Urel(Rw)were beyond the goals,and the accuracy and precision should be improved. Conclusions In the management of determination quality,the insufficiency of determination could be found by analyzing MU and 2 main components which are assessed with the data of IQC and EQA and CNAS technical reports,which can be improved further.

    Immune protection of Streptococcus iniae M-like protein mutant strain BY-1 ΔsimA
    YANG Chengliang, LI Congrong
    2017, 32(7):  647-651.  DOI: 10.3969/j.issn.1673-8640.2017.07.021
    Asbtract ( 139 )   HTML ( 1)   PDF (843KB) ( 628 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To investigate the immune protection of Streptococcus iniae M-like protein mutant strain BY-1 ΔsimA being used as a live attenuated vaccine to protect mice from Streptococcus iniae infection. Methods Allelic exchange mutagenesis was performed to construct Streptococcus iniae M-like protein mutant strain BY-1 ΔsimA. Shuttle vector pVE6007,which was sensitive to temperature,was used and could replicate in Streptococcus,to screen mutant strain BY-1 ΔsimA in a high efficiency. Kunming mice were immunized by the verified mutant strain BY-1 ΔsimA by intra-peritoneal injection,and infected with lethal dose Streptococcus iniae BY-1 after 21 d. The observation lasted for 15 d,and the accumulated death number was counted. Results Only 13.3% mice immunized with Streptococcus iniae mutant strain BY-1 ΔsimA were dead,resulting in 77.8% relative percentage survival(RPS),which showed no statistical significance for wild type BY-1 whole-cell killed vaccine(P>0.05),which had 55.5% of RPS. Conclusions Streptococcus iniae mutant strain BY-1 ΔsimA could effectively protect mice from Streptococcus iniae infection,which was an ideal live attenuated vaccine candidate.

    CONTENTS IN BRIEF
    Immune protection of Streptococcus iniae M-like protein mutant strain BY-1 ΔsimA
    YANG Chengliang, LI Congrong
    2017, 32(7):  647-651.  DOI: 10.3969/j.issn.1673-8640.2017.07.021
    Asbtract ( 96 )   HTML ( 0)   PDF (1073KB) ( 336 )  
    References | Related Articles | Metrics

    Objective To investigate the immune protection of Streptococcus iniae M-like protein mutant strain BY-1 ΔsimA being used as a live attenuated vaccine to protect mice from Streptococcus iniae infection. Methods Allelic exchange mutagenesis was performed to construct Streptococcus iniae M-like protein mutant strain BY-1 ΔsimA. Shuttle vector pVE6007,which was sensitive to temperature,was used and could replicate in Streptococcus,to screen mutant strain BY-1 ΔsimA in a high efficiency. Kunming mice were immunized by the verified mutant strain BY-1 ΔsimA by intra-peritoneal injection,and infected with lethal dose Streptococcus iniae BY-1 after 21 d. The observation lasted for 15 d,and the accumulated death number was counted. Results Only 13.3% mice immunized with Streptococcus iniae mutant strain BY-1 ΔsimA were dead,resulting in 77.8% relative percentage survival(RPS),which showed no statistical significance for wild type BY-1 whole-cell killed vaccine(P>0.05),which had 55.5% of RPS. Conclusions Streptococcus iniae mutant strain BY-1 ΔsimA could effectively protect mice from Streptococcus iniae infection,which was an ideal live attenuated vaccine candidate.

    Orginal Article
    Clinical characteristics of a case of near-tetraploidy acute myeloid leukemia
    ZHU Jianfeng, WANG Beili, GUO Wei, PAN Baishen
    2017, 32(7):  652-655.  DOI: 10.3969/j.issn.1673-8640.2017.07.022
    Asbtract ( 239 )   HTML ( 0)   PDF (1448KB) ( 438 )  
    Figures and Tables | References | Related Articles | Metrics

    Objective To report a case of near-tetraploidy acute myeloid leukemia(NT-AML),and to analyze its clinical,morphological and cytogenetic characteristics. Methods A case of NT-AML was reported,and its morphology,immunophenotype,treatment and prognosis were evaluated. Morphological characteristics included blast size,irregularity of nuclear contours,cytoplasmic vacuoles,granules and dysplasia. Results This case described acute myeloid leukemia with a near-tetraploid karyotype. Immunophenotype of blasts was consistent with myeloid leukemia phenotype,without expressing lymphoid marker. Blasts were characterized by hyper-granule in cytoplasm,resembling abnormal promyelocytes. It was also showed myelodysplasia-related morphologic changes in myeloid lineages. Conclusions NT-AML occurs in elder males,which exhibits large blast size and is associated with myelodysplasia. It is typically associated with a poor treatment response,low complete remission and short survival. Near-tetraploid karyotype could be used as a sign of poor prognosis with low survival.

    Role of CD73 in cancer
    GAO Yaoyi, MA Xiaolu, WU Jiong, GUO Wei, PAN Baishen
    2017, 32(7):  656-662.  DOI: 10.3969/j.issn.1673-8640.2017.07.023
    Asbtract ( 304 )   HTML ( 0)   PDF (899KB) ( 448 )  
    References | Related Articles | Metrics

    Purine plays an important role in cancer progression,and is regulated by a series of nucleotidases. CD73 is one of key enzymes. CD73 can catalyze adenosine monophosphate(AMP)breakdown to adenosine,and is found to be overexpressed in many types of cancers. There are various factors and mechanisms for regulating the expression of CD73. More and more studies have shown that CD73 is a key regulatory molecule of in vitro cancer cell proliferation,migration and invasion and in vivo tumor angiogenesis and tumor immune escape. Evidences in in vivo model prove that targeted blockade of CD73 could be a favorable therapeutic approach for cancer patients. This review will summarize the roles of CD73 in cancer development,including tumor angiogenesis,tumor growth and metastasis,suppressing the efficiency of immune response and the status of anti-CD73 cancer therapy.